New Food and Drug Administration documents show the agency knew almost nothing about how well mRNA boosters might work when it okayed them. It was mainly using public Israeli data like everyone else.
0 subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.